Publication:
Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features.

Simple item page
dc.contributor.authorRuiz de Alegria, C
dc.contributor.authorRodriguez-Bano, J
dc.contributor.authorCano, ME
dc.contributor.authorHernandez-Bello, JR
dc.contributor.authorCalvo, J
dc.contributor.authorRoman, E
dc.contributor.authorDiaz, MA
dc.contributor.authorPascual, A
dc.contributor.authorMartinez-Martinez, L
dc.contributor.authoraffiliation[Ruiz de Alegría,C; Cano,ME; Calvo,J; Román,E; Martínez-Martínez,L] Service of Microbiology, University Hospital Marqués de Valdecilla-IFIMAV, Santander, Spain. [Rodríguez-Baño,J] Infectious Disease Unit, University Hospital Virgen Macarena, Seville, Spain. [Rodríguez-Baño,J; Hernández-Bello,JR] Departments of Medicine, University Hospital Virgen Macarena, Seville, Spain. [Díaz,MA; Pascual,A] Service of Microbiology, University Hospital Virgen Macarena, Seville, Spain. [Pascual,A] Departments of Microbiology, University of Seville, Seville, Spain. [Martínez-Martínez,L] Department of Molecular Biology, University of Cantabria, Santander, Spain.es
dc.contributor.funderThis study was partially supported by an unrestricted grant from Wyeth Laboratories (Spain), by the Ministerio de Sanidad y Consumo,Instituto de Salud Carlos III-FEDER, by the Spanish Network for Research in Infectious Diseases (grant REIPI RD06/0008), by FIS(grants PI070190 and INT08/151), and by the Junta de Andalucía(grants 0048/2008, CTS-5209, and 0034/2009). E.R. is supported by IFIMAV, Cantabria, Spain. J.R.-B. reports that he has been a consultant for Wyeth, Merck, and Pfizer, has served as speaker for Wyeth, Merck, Pfizer, AstraZeneca, and GlaxoSmithKline, and has received research support from Merck and Wyeth. A.P. reports that he has been a consultant for Merck and Pfizer, has served as a speaker for Wyeth, AstraZeneca, Merck, and Pfizer, and has received research support from Merck, Pfizer, and Wyeth.L.M.-M. reports that he has been a consultant for Wyeth and Pfizer, has served as speaker for Wyeth, Merck, Pfizer, and Janssen-Cilag, and has received research support from Merck, Wyeth, and Janssen-Cilag.
dc.date.accessioned2015-11-26T13:06:46Z
dc.date.available2015-11-26T13:06:46Z
dc.date.issued2011-03
dc.descriptionJournal Article; Multicenter Study; Research Support, Non-U.S. Gov't;es
dc.description.abstractExtended-spectrum β-lactamases (ESBL) of the CTX-M, SHV, and TEM families were recognized in 76 (67%), 31 (27%), and 6 (5%) isolates, respectively, among 162 ESBL-producing Klebsiella pneumoniae (ESBL-Kp) strains obtained in a multicenter study in Spain. Predisposing factors for ESBL-Kp acquisition included invasive procedures, mechanical ventilation, and previous antimicrobial use.es
dc.description.versionYeses
dc.identifier.citationRuiz de Alegría C, Rodríguez-Baño J, Cano ME, Hernández-Bello JR, Calvo J, Román E, et al. Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features. J. Clin. Microbiol.. 2011 Mar; 49(3):1134-6es
dc.identifier.doi10.1128/JCM.02514-10
dc.identifier.essn1098-660X
dc.identifier.pmid21191059
dc.identifier.urihttp://hdl.handle.net/10668/2080
dc.journal.titleJournal of clinical microbiology
dc.language.isoen
dc.publisherAmerican Society for Microbiologyes
dc.relation.publisherversionhttp://jcm.asm.org/content/49/3/1134.abstractes
dc.rights.accessRightsopen access
dc.subjectAntibacterianoses
dc.subjectRecién nacidoes
dc.subjectInfecciones por klebsiellaes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agentses
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Infant::Infant, Newbornes
dc.subject.meshMedical Subject Headings::Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Negative Bacterial Infections::Enterobacteriaceae Infections::Klebsiella Infectionses
dc.subject.meshMedical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Klebsiella::Klebsiella pneumoniaees
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Microbiological Techniques::Microbial Sensitivity Testses
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalencees
dc.subject.meshMedical Subject Headings::Geographicals::Geographic Locations::Europe::Spaines
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Amidohydrolases::beta-Lactamaseses
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adultes
dc.titleKlebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features.es
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ruiz_KlebsiellaPneumoniaeStrains.pdf
Size:
52.94 KB
Format:
Adobe Portable Document Format
Description:
Artículo publicado
Download

Collections

SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía